|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2010-7-27
|
|
pubmed:abstractText |
The objective of this study was to identify subgroups of patients with castrate-resistant prostate cancer (CRPC) who had a prolonged response to combined dexamethasone and diethylstilbestrol (DS) therapy by constructing a prognostic index.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:AbelmanWalterW,
pubmed-author:BrockCathrynC,
pubmed-author:DawkinsGuyG,
pubmed-author:HarlandSteveS,
pubmed-author:OliverTimT,
pubmed-author:PowlesThomasT,
pubmed-author:SanittAdamA,
pubmed-author:ShamashJonathanJ,
pubmed-author:SonpavdeGuruG,
pubmed-author:StebbingJustinJ,
pubmed-author:SweeneyChrisC,
pubmed-author:WilsonPeterP
|
|
pubmed:copyrightInfo |
Copyright (c) 2010 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3595-602
|
|
pubmed:meshHeading |
pubmed-meshheading:20564115-Aged,
pubmed-meshheading:20564115-Aged, 80 and over,
pubmed-meshheading:20564115-Androgen Antagonists,
pubmed-meshheading:20564115-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20564115-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20564115-Dexamethasone,
pubmed-meshheading:20564115-Diethylstilbestrol,
pubmed-meshheading:20564115-Humans,
pubmed-meshheading:20564115-Male,
pubmed-meshheading:20564115-Middle Aged,
pubmed-meshheading:20564115-Prognosis,
pubmed-meshheading:20564115-Prostate-Specific Antigen,
pubmed-meshheading:20564115-Prostatic Neoplasms,
pubmed-meshheading:20564115-Reproducibility of Results,
pubmed-meshheading:20564115-Retreatment
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology, Barts and the London National Health Service Trust, London, United Kingdom.
|
|
pubmed:publicationType |
Journal Article
|
